Median Diagnostics Inc. (XKON:233250)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,690
+1,700 (14.18%)
At close: Oct 1, 2025
14.18%
Market Cap20.94B
Revenue (ttm)7.86B
Net Income (ttm)-567.58M
Shares Out1.75M
EPS (ttm)-496.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1
Average Volume10
Open13,690
Previous Close11,990
Day's Range13,690 - 13,690
52-Week Range11,000 - 18,500
Beta0.17
RSI46.11
Earnings Daten/a

About Median Diagnostics

Median Diagnostics Inc. develops, produces, and sells diagnostic methods and kits for early diagnosis and constant monitoring of infectious diseases outbreak in animals and human. Its products include PCR sets for pigs, ruminants, poultry, equine, canine and feline, and shrimps; rapid kits for pigs, ruminants, poultry, canine, feline, erwinia amylovora, and bovine pregnancy; ELISA for pigs, ruminants, avians, and horses; standard reagents, including AGID, HI, and FA; and antigen/antibody, including antibodies for veterinary diagnostics, and ant... [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 1999
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 233250
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.